Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.802
+0.008 (0.29%)
Sep 16, 2026, 5:35 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €229 million as of September 16, 2026. Its market cap has increased by 5.99% in one year.
Market Cap
229.00M
Enterprise Value
225.11M
Revenue
15.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.80
ChartMarket Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 229.00M, an increase of 87.71%. That is a compound annual growth rate of 6.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 229.00M | -6.62% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.78B |
| Laboratorios Farmaceuticos Rovi | 2.93B |
| Almirall | 2.23B |
| Faes Farma | 1.39B |
| Clínica Baviera | 907.48M |
| Prim, S.A. | 216.01M |
| Laboratorio Reig Jofre | 214.11M |
| Atrys Health | 210.64M |